1. Home
  2. BWAY vs KEQU Comparison

BWAY vs KEQU Comparison

Compare BWAY & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • KEQU
  • Stock Information
  • Founded
  • BWAY 2003
  • KEQU 1906
  • Country
  • BWAY Israel
  • KEQU United States
  • Employees
  • BWAY N/A
  • KEQU N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • KEQU Medical Specialities
  • Sector
  • BWAY Health Care
  • KEQU Industrials
  • Exchange
  • BWAY Nasdaq
  • KEQU Nasdaq
  • Market Cap
  • BWAY 207.4M
  • KEQU 183.8M
  • IPO Year
  • BWAY 2019
  • KEQU N/A
  • Fundamental
  • Price
  • BWAY $10.21
  • KEQU $48.21
  • Analyst Decision
  • BWAY Strong Buy
  • KEQU
  • Analyst Count
  • BWAY 3
  • KEQU 0
  • Target Price
  • BWAY $13.17
  • KEQU N/A
  • AVG Volume (30 Days)
  • BWAY 92.0K
  • KEQU 27.6K
  • Earning Date
  • BWAY 03-11-2025
  • KEQU 03-12-2025
  • Dividend Yield
  • BWAY N/A
  • KEQU N/A
  • EPS Growth
  • BWAY N/A
  • KEQU 102.06
  • EPS
  • BWAY 0.09
  • KEQU 5.90
  • Revenue
  • BWAY $41,016,000.00
  • KEQU $220,026,000.00
  • Revenue This Year
  • BWAY $349.63
  • KEQU N/A
  • Revenue Next Year
  • BWAY $27.16
  • KEQU N/A
  • P/E Ratio
  • BWAY $66.18
  • KEQU $8.34
  • Revenue Growth
  • BWAY 29.04
  • KEQU 9.44
  • 52 Week Low
  • BWAY $4.61
  • KEQU $29.95
  • 52 Week High
  • BWAY $11.79
  • KEQU $71.33
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 52.70
  • KEQU 37.10
  • Support Level
  • BWAY $8.88
  • KEQU $42.50
  • Resistance Level
  • BWAY $10.54
  • KEQU $51.55
  • Average True Range (ATR)
  • BWAY 0.58
  • KEQU 3.66
  • MACD
  • BWAY 0.03
  • KEQU -0.64
  • Stochastic Oscillator
  • BWAY 68.98
  • KEQU 39.93

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Share on Social Networks: